Newsletter of MEDICA | View in browser | Deutsch | Print
Header of MEDICA Newsletter

Tailor-made tumor therapy thanks to epigenetics

Dear Sir or Madam,

Tumors of the central nervous system have different molecular properties. Therefore, an exact classification of the tumors helps in the selection of a suitable therapy. Researchers at the University of Heidelberg have now developed an algorithm-based method for the precise determination of these types of tumors. Read more in our current news.

I wish you a nice first week of spring,

Julia Unverzagt
Editorial team MEDICA-tradefair.com
image: 12 - 15 November 2018, MEDICA - World Forum for Medicine in Düsseldorf

Table of Contents

Topic of the Month: Personalized cancer medicine
Newsletter Service
RSS Service
Newsletter Archive

Personalized medicine: a paradigm shift is gaining momentum

Topic of the Month

mage: A group of physicians is holding large colorful puzzle pieces in their hands and is putting them together; Copyright: panthermedia.net/Andriy Popov
Personalized medicine does not follow a "one-size-fits-all" treatment approach but emphasizes a "tailor-made" paradigm, meaning a treatment is customized to each individual person's case. For patients, this increases the chances of treatment success and means fewer side effects. While the approach originates in the field of oncology, it is now also increasingly applied to other disease patterns.
Read more in our Topic of the Month:
Personalized medicine: a paradigm shift is gaining momentum
Personalized Medicine – focused on healing

Research & Technology

New method manages and stores data from millions of nerve cells - in real time

Recent developments in neuroscience set high requirements for sophisticated data management, not least when implantable Brain Machine Interfaces are used to establish electronic communication between the brain's nerve cells and computers.
read more
To top

Research & Technology

Research project on dangerous hospital germ extended

German Research Foundation extends project aimed at combating multi-resistant Acinetobacter baumannii strains.
read more
To top

Research & Technology

Mapping a genetic risk

UCalgary researchers discover an important clue to help predict disease.
read more
To top

Research & Technology

WSU researchers see gene influencing performance of sleep-deprived people

Washington State University researchers have discovered a genetic variation that predicts how well people perform certain mental tasks when they are sleep deprived.
read more
To top

Newsletter Service

You like our newsletter? Then please recommend us: Forward this newsletter or the link www.MEDICA.de/news_login_2 to your friends and colleagues.

If you have difficulties with your order, please write an e-mail to redaktion@medica.de.
To top
Legal disclaimer

Messe Düsseldorf GmbH
Messeplatz, Stockumer Kirchstr. 61
40474 Düsseldorf, Germany

Phone: +49 (0)211 / 4560-01
Fax: +49 (0)211 / 4560-668
www.messe-duesseldorf.de
info@messe-duesseldorf.de

County Court Düsseldorf HRB 63

Board of Managing Directors: Werner M. Dornscheidt (Chairman), Hans Werner Reinhard, Joachim Schäfer, Bernhard Stempfle

Chairman of Supervisory Board: Mayor Thomas Geisel

Facebook Twitter LinkedIn YouTube

Should you no longer wish to receive our newsletter, please click here.